Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Return on Capital Employed (2017 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Return on Capital Employed for 9 consecutive years, with 0.5% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 52.0% to 0.5% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.5% through Dec 2025, up 52.0% year-over-year, with the annual reading at 0.58% for FY2025, 49.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.5% at Rhythm Pharmaceuticals, up from 0.55% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.36% in Q2 2021, with the low at 1.12% in Q1 2024.
  • Average Return on Capital Employed over 5 years is 0.67%, with a median of 0.63% recorded in 2022.
  • The sharpest move saw Return on Capital Employed plummeted -56bps in 2024, then surged 52bps in 2025.
  • Over 5 years, Return on Capital Employed stood at 0.57% in 2021, then grew by 9bps to 0.52% in 2022, then fell by -24bps to 0.64% in 2023, then plummeted by -58bps to 1.01% in 2024, then soared by 51bps to 0.5% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.5%, 0.55%, and 0.71% for Q4 2025, Q3 2025, and Q2 2025 respectively.